FDA Launches Fast-Track Reviews for Key Medicines
New initiative cuts drug review time to as little as 30 days
The U.S. Food and Drug Administration (FDA) announced Tuesday a new fast-track initiative...
BioNTech Acquires CureVac for $1.25 Billion in Share Deal
Deal Overview
German biotech firm BioNTech has announced the acquisition of its rival CureVac for approximately $1.25 billion in BioNTech shares. This move aims to...
AstraZeneca Eyes $80 Billion Goal with New Cancer Drugs
AstraZeneca (AZN) is aiming to meet its ambitious $80 billion target by 2030, with three promising cancer treatments unveiled in recent studies. The drugs...
New Covid Variant NB.1.8.1 Spreads Globally, Concerns Rise
A new COVID variant, NB.1.8.1, is gaining traction globally, including in the United States. The World Health Organization (WHO) announced that it is monitoring...
FDA Limits COVID Vaccine Access, Prioritizes High-Risk Groups
The Trump administration’s recent decision to limit approval for seasonal COVID-19 shots to seniors and those at high risk has raised concerns about accessibility...
Cat Food Recall Issued After Bird Flu Linked to Cat’s Death
Northwest Naturals is recalling a line of its raw and frozen cat food after authorities confirmed that a contaminated batch caused the death of...